| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021263278-A1 | Rev-erb agonists for the treatment of th17-mediated inflammatory disorders | 2020-06-23 |
| CN-111285859-A | 2,4, 5-trisubstituted pyrimidine compounds with HIV-1 reverse transcriptase as target, and preparation method and application thereof | 2020-04-02 |
| CN-111285859-B | 2,4, 5-trisubstituted pyrimidine compounds with HIV-1 reverse transcriptase as target, and preparation method and application thereof | 2020-04-02 |
| WO-2021071802-A1 | Aryl heterocyclic compounds as kv1.3 potassium shaker channel blockers | 2019-10-07 |
| CN-113164476-A | Small molecule inhibitor of DYRK1/CLK and application thereof | 2018-09-28 |
| US-2022041590-A1 | Small molecule inhibitors of dyrk/clk and uses thereof | 2018-09-28 |
| US-2020039989-A1 | Small molecule inhibitors of dyrk/clk and uses thereof | 2018-03-01 |
| JP-2020511542-A | Substituted [5,6] cyclo-4 (3H) -pyrimidinones as anticancer agents | 2017-05-21 |
| US-2020055867-A1 | Substituted [5,6]cyclic-4(3h)-pyrimidinones as anticancer agents | 2017-05-21 |
| CN-110381950-B | Substituted [5,6] cyclo-4 (3H) -pyrimidinones as anticancer agents | 2017-05-21 |
